The Influence of Pharmacokinetic Differences between Bezafibrate and Ciprofibrate on Gastric Toxicity in the Rat

Abstract

Get full access to this article

View all access options for this article.

References

Edelson J. , Benziger DP , Arnold A. & Bayler AL Blood levels, tissue distribution and the duration of action in rats of ciprofibrate, a new hypolipidaemic agent. Atherosclerosis 1979; 30: 351-7.

Schmidt FH , Stegmeier K. , Stork H. , Endale R. & Koch K. Pharmacokinetics and metabolism of bezafibrate in animals. In L ipoproteins and Coronary Heart Disease, eds H Cretan , P Long & T Schettler , pp. 102-105. G. Gerhard Witzstrock Publishing House, 1980.

Gibaldi M. Biopharmaceuticals and Clinical Pharmacokinetics, pp. 24-27. Philadelphia : Lea and Febiger, 1984.